Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
Giloteaux, Ludovic, O'Neal, Adam, Castro-Marrero, Jesús et al. · Journal of translational medicine · 2020 · DOI
Quick Summary
This study looked at tiny particles called extracellular vesicles (EVs) in the blood of ME/CFS patients and compared them to healthy people. The researchers found that ME/CFS patients had more of these small particles, and the chemical messengers (cytokines) inside and around them showed unusual patterns of interaction that differed from healthy controls. This suggests that immune system signaling may be working differently in ME/CFS.
Why It Matters
This study provides novel evidence that immune dysregulation in ME/CFS may involve abnormal cytokine communication patterns rather than simply elevated or decreased individual cytokine levels. Understanding these altered immune network dynamics could lead to better diagnostic markers and targeted therapeutic approaches for ME/CFS patients.
Observed Findings
ME/CFS patients had significantly higher levels of extracellular vesicles in the 30-130 nm size range compared to healthy controls.
Cytokine network analysis in ME/CFS plasma showed 13 inverse (negative) correlations among cytokines, particularly driven by Interferon gamma-induced protein 10 (IP-10), whereas no inverse relationships were found in control plasma.
Control EV networks showed 2.5 times more significant inter-cytokine interactions than ME/CFS EV networks.
Typical EV markers (CD63, CD81, TSG101, HSP70) were confirmed in isolated vesicles from both groups via Western blotting.
Absolute cytokine concentrations in plasma and isolated EVs did not show significant differences between ME/CFS patients and controls.
Inferred Conclusions
Extracellular vesicle levels are elevated in ME/CFS and may serve as a biological marker of disease.
Cytokine dysregulation in ME/CFS involves abnormal communication patterns (correlation networks) rather than simple elevation or reduction of individual cytokines.
Immune dysregulation in ME/CFS manifests differently in plasma versus extracellular vesicles, suggesting compartmentalized immune signaling abnormalities.
Remaining Questions
Do elevated EV levels and altered cytokine networks precede ME/CFS symptom onset, or do they develop as a consequence of chronic illness?
What This Study Does Not Prove
This study does not establish causation—elevated EVs and altered cytokine correlations are associated with ME/CFS but do not prove they cause the disease. The pilot design and small subset analyzed for cytokine networks (n=19) limit the strength of conclusions. Cross-sectional design prevents determination of whether these findings predate illness onset or result from it.
What specific mechanisms drive the IP-10-centered inverse cytokine correlations observed in ME/CFS patients?
Would larger sample sizes confirm the cytokine network patterns observed in this pilot study, and do these patterns correlate with disease severity or symptom profiles?
Do functional studies reveal whether EVs from ME/CFS patients transmit altered immune signals to recipient cells differently than control EVs?